Acuña, L., Hamadat, S., Corbalán, N.S., González-Lizárraga, F., dos-Santos-Pereira, M., Rocca, J., Sepúlveda Díaz, J., Del-Bel, E., Papy-García, D., Chehín, R.N., et al. (2019). Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates. Cells 8.
Appel, S.H., Beers, D.R., and Henkel, J.S. (2010). T cell-microglial dialogue in Parkinson’s disease and amyotrophic lateral sclerosis: are we listening? Trends in Immunology 31, 7–17.
Bartels, A.L., and Leenders, K.L. (2007). Neuroinflammation in the pathophysiology of Parkinson’s disease: Evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Movement Disorders 22, 1852–1856.
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008). Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119.
Chorro, L., Suzuki, M., Chin, S.S., Williams, T.M., Snapp, E.L., Odagiu, L., Labrecque, N., and Lauvau, G. (2018). Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun 9.
Ding, J., Zhang, J., Wang, X., Zhang, L., Jiang, S., Yuan, Y., Li, J., Zhu, L., and Zhang, K. (2017). Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson’s disease. J Neural Transm 124, 353–360.
Kim, I.Y., O’Reilly, É.J., Hughes, K.C., Gao, X., Schwarzschild, M.A., Hannan, M.T., Betensky, R.A., and Ascherio, A. (2018). Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts. Neurology 90, e1646–e1653.
Neher, J.J., Neniskyte, U., Zhao, J.-W., Bal-Price, A., Tolkovsky, A.M., and Brown, G.C. (2011). Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death. The Journal of Immunology 186, 4973–4983.
Reynolds, A.D., Banerjee, R., Liu, J., Gendelman, H.E., and Mosley, R.L. (2007). Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease. Journal of Leukocyte Biology 82, 1083–1094.
Su, X., Maguire-Zeiss, K.A., Giuliano, R., Prifti, L., Venkatesh, K., and Federoff, H.J. (2008). Synuclein activates microglia in a model of Parkinson’s Disease.
Neurobiol Aging 29, 1690–1701.
Wang, Q., Liu, Y., and Zhou, J. (2015). Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener 4, 19.
Zhang, W., Phillips, K., Wielgus, A.R., Liu, J., Albertini, A., Zucca, F.A., Faust, R., Qian, S.Y., Miller, D.S., Chignell, C.F., et al. (2011).
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease. Neurotox Res 19, 63–72.